Long-Term Quality of Life in Patients With Metastatic Melanoma Treated With Checkpoint Inhibitors

NCT03326973 · clinicaltrials.gov ↗

COMPLETED

Status

107

Enrollment

OTHER

Sponsor class

Conditions

Metastatic Melanoma

Interventions

BEHAVIORAL: EuroQoL EQ-5D-3L
BEHAVIORAL: EORTC QLQ-C30
OTHER: PRO-CTCAE
BEHAVIORAL: Fatigue severity score questionnaire
BEHAVIORAL: The COST
BEHAVIORAL: Physician information

Sponsor

Memorial Sloan Kettering Cancer Center